No Data
Gangtong Healthcare: First Quarter Report 2025
Gangtong Healthcare: 2024 Annual Report Summary
Hong Kong Express Healthcare: 2024 Annual Report
Hong Kong Tong Medical (301515.SZ) announced its performance for 2024, with a net income of 14.4219 million yuan, a year-on-year decrease of 82.64%.
Hong Kong Tong Medical (301515.SZ) released its annual report for 2024, during the reporting period, the company achieved revenue of 7...
Hong Kong Tong Medical (301515.SZ): Cumulatively repurchased 2.3% of shares.
On April 1, Gelonghui reported that Hong Kong Tong Medical (301515.SZ) announced that as of March 31, 2025, the company had repurchased a total of 2,298,786 shares through a dedicated securities account for share buybacks via centralized bidding, accounting for 2.30% of the company's total share capital. The maximum fill price was 19.68 yuan/share, the minimum fill price was 17.30 yuan/share, and the total amount of the transaction was 43,438,124.64 yuan (excluding transaction fees). The implementation of this stock repurchase is in accordance with the company's established share buyback plan and relevant laws and regulations.
Hong Kong Tong Medical (301515.SZ): has cumulatively repurchased 1.25% of its shares.
On February 26, the company Hongtong Medical (301515.SZ) announced that as of February 24, 2025, it had repurchased shares through a designated securities account for Share Buyback via centralized bidding, with a total number of shares repurchased reaching 1,251,691, accounting for 1.25% of the company's total share capital. The highest Fill Price was 19.68 yuan/share, the lowest Fill Price was 17.30 yuan/share, and the total amount of the transaction was 23.4694 million yuan (excluding transaction fees).
Sichuan Gangtong Medical Equipment Group Co., Ltd (SZSE:301515) Delivered A Weaker ROE Than Its Industry